SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-462653
Filing Date
2012-11-09
Accepted
2012-11-09 13:18:11
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d422473d10q.htm 10-Q 662231
2 SECTION 302 CEO CERTIFICATION d422473dex311.htm EX-31.1 9712
3 SECTION 302 CFO CERTIFICATION d422473dex312.htm EX-31.2 9475
4 SECTION 906 CEO CERTIFICATION d422473dex321.htm EX-32.1 4719
5 SECTION 906 CFO CERTIFICATION d422473dex322.htm EX-32.2 4517
  Complete submission text file 0001193125-12-462653.txt   4238140

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT kalop-20120930.xml EX-101.INS 583535
7 XBRL TAXONOMY EXTENSION SCHEMA kalop-20120930.xsd EX-101.SCH 47812
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kalop-20120930_cal.xml EX-101.CAL 51563
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kalop-20120930_def.xml EX-101.DEF 223757
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE kalop-20120930_lab.xml EX-101.LAB 337211
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kalop-20120930_pre.xml EX-101.PRE 263959
Mailing Address 260 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080
Business Address 260 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080 650.243.3100
KALOBIOS PHARMACEUTICALS INC (Filer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54735 | Film No.: 121192742
SIC: 2834 Pharmaceutical Preparations